For instance, on January 3, 2024, Glenmark Pharmaceuticals Ltd., an Indian multinational pharmaceutical company, announced that it had launched a biosimilar of the anti-diabetic drug, Liraglutide, in India
Acute peripheral administration of synthetic human GLP-1 (7-36 amide) decreases circulating IL-6 in obese patients with type 2 diabetes mellitus: a potential role for GLP-1 in modulation of the diabetic pro-inflammatory state
This FAQ section provides clear, practical answers to help you understand how methylcobalamin fits into a broader routine focused on energy, clarity and overall wellness
Dng bt c lc no trong ngy, u tin bui sng v tra.
in your cells
doi: 10.3389/fendo.2022.818537 63